AKYNZEO
These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous useInitial U.S. Approval: 2018
8e47618e-af46-4d82-94e8-1507c042252d
HUMAN PRESCRIPTION DRUG LABEL
Dec 10, 2023
Helsinn Therapeutics (U.S.), Inc.
DUNS: 829472583
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Fosnetupitant and Palonosetron
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Fosnetupitant and Palonosetron
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Fosnetupitant and Palonosetron
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Netupitant and Palonosetron
Product Details
FDA regulatory identification and product classification information